Product Information
BDA-366 is a potential anticancer agent that inhibits apoptosis by inhibiting the release of cytochrome c from mitochondria. It has shown potent antitumor activity in vitro and in vivo and can be used to treat cancer. BDA-366 binds to the bcl-2 protein and prevents it from forming heterodimers with pro-apoptotic proteins such as bax, resulting in inhibition of mitochondrial membrane depolarization. BDA-366 also inhibits the production of pro-apoptotic proteins such as cytochrome c, which leads to cell death.
Chemical properties
Technical inquiry about: 3D-JBD22600 BDA-366
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.